![]() |
|
Editorial
The Healing Power of Time: The Case of Lateral Epicondylitis
JUAN J. CANOSO, MD, Adjunct Professor of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA Address reprint requests to Dr. J.J. Canoso. E-mail: juan123canoso@prodigy.net.mx Lateral epicondylitis can be most distressing. I say this not from years of being interested in this condition, but from my own experience 3 nights ago when my car hit a pothole and I instinctively clasped the steering wheel. A minor ache present for a couple of weeks on my right lateral elbow suddenly became unbearable. Pain extended along the "wad of three" muscles in the lateral forearm. Any attempt to hold something is now cause for excruciating pain; and that sharp tenderness described at the epicondylar enthesis of extensor carpi radialis brevis (ECRB, I have). And if I resist dorsiflexion of the wrist or hyperextension of the middle finger, pain increases acutely. Only today, being right-handed, was I able to inflate the blood-pressure cuff, and this with a lot of pain, which highlights the antagonistic action of ECRB upon grasping. Thus, no personal setting could be more agreeable than mine to comment on the article by Smidt, et al in this issue of The Journal1. Their study, which is based on the merging of 2 prospective randomized trials2,3, clearly confirms that lateral epicondylitis is a self-limited condition in most patients. As it turns out, severe pain, long duration of symptoms, and presence of concomitant neck pain at baseline are associated with higher pain scores at 12 months. Severe pain I have; however, my condition is recent and my neck doesn't hurt: one bad and 2 good signs that should reassure me for the long term. Is lateral epicondylitis the sole example of the healing power of time in soft tissue rheumatology? Not at all. Let us take, as an example, plantar heel pain. Many a treatment has been used for this condition, including insoles, heel pads, stretching exercises, night splints, corticosteroid infiltrations, laser therapy, ultrasound therapy, shock-wave therapy, and surgery with no convincing results4. Fortunately, regardless of treatment, as in lateral epicondylitis, pain in most cases gradually fades within 4 years5,6. In idiopathic olecranon bursitis, a steroid injection with the proper precautions is both effective and safe7. However, although data are limited, if continuing trauma is avoided, most effusions subside within 3 months8. In frozen shoulder, although steroid injections plus physiotherapy provide early benefit9, not only does pain disappear, but much of the lost motion is restored within one to 3 years10. One further example may be chronic shoulder tendinosis, an entity that in most instances is believed to result from subacromial impingement. However, since debridement appears to give the same results as acromionectomy, one cannot help but wonder about the very pathogenetic tenet of this condition11. To further fuel skepticism, in one trial, supervised exercises led to the same excellent result as arthroscopic decompression12. Finally, popliteal cysts in children, which by being primary (without knee pathology) differ from the adult form of the disease, regress with time13. There are, of course, syndromes that are clearly helped by our therapies. Of these, trigger finger, de Quervain's tenosynovitis, carpal tunnel syndrome, and iliotibial band syndrome are often relieved by corticosteroid infiltrations. Non-insertional Achilles tendinopathy is helped by eccentric exercises14. And there are conditions, such as trochanteric syndrome, anserine syndrome, retrocalcaneal bursitis, Morton's neuroma, and myofascial pain, that are benefitted by our therapies in the short term, but their longterm course is largely unknown. Some of the uncertainties surrounding corticosteroid injections in these entities, in particular hard to reach structures such as the shoulder, the retrocalcaneal bursa, the plantar fascia, and Morton's neuroma, may reflect inaccuracies in needle placement. As shown by Naredo, et al, ultrasound-guided injections in the shoulder15 may be more effective than blind injections. Ultrasound-based corticosteroid injection trials are definitely needed. With our training in medicine, we strive to heal based on sound therapies that should completely or partially reverse the processes of disease. However, the efficacy of our therapies in many of the soft tissue syndromes is limited. Thus, our apparent success (or failure) may largely depend on when in the regressive course of the condition we happen to treat a patient. Following this line of thought, and in contrast to other areas of rheumatology, early detection may not portend a better result, but rather the opposite! It should not be surprising, given this scenario, that disappointed patients often turn to alternative therapies. These, by a happy combination of receiving these patients late in their disease course (and therefore closer to spontaneous resolution), plus their clever protracted nature, are assured of success. Returning to the article by Smidt, et al, a long duration of elbow complaints at baseline is an indicator of poor prognosis. While this appears to clash with the self-limited model mentioned above, these patients probably represent longterm failures from previous cohorts. Severe symptoms and concomitant neck pain at baseline, the 2 remaining indicators, raise the possibility that some of these patients, and perhaps some of the patients with long-standing pain as well, had fibromyalgia. This amplifying and perpetuating condition was not excluded in the original studies. It should be mentioned that in fibromyalgia, unless there is concomitant lateral epicondylitis, resisted wrist extension does not cause epicondylar pain (Table 1; personal observations). Finally, I am also distressed by the lack of definition of "concomitant shoulder pain" and "concomitant neck pain." Although radiculopathy was an exclusion criterion, as a clinician I would like to know whether the shoulder pain had a tendinous or capsular pattern and whether the neck pain was ipsilateral or contralateral to bending or rotation. Clearly, the presence of upstream tendinopathies at baseline could give clues to the underlying factor(s) leading to a poor outcome in lateral epicondylitis.
Given the above, after an anatomically-minded assessment including a search for fibromyalgia, what should a rheumatologist tell patients with lateral epicondylitis? (A) That their condition, left on its own, sooner or later will improve. (B) To modify or cut down on any identified offending activities (a forearm support band may decrease the damaging forces involved). (C) From common sense rather than demonstration, to initiate exercises promptly (shoulder pendular, elbow and wrist active motion, deep transverse friction massage, then stretching and gentle resisted motion) to maintain arcs of motion, avoid muscle atrophy, and perhaps improve longterm outcome. (D) Some patients may request a corticosteroid infiltration. Let them know that these injections, which improve many patients in the short term, may have untoward effects. One is additional pain prior to improvement16. I have seen serious postinjection pain including features of sympathetic dystrophy. The second concern is that injected patients may fare worse in the long term than those not injected3. (E) Patients may inquire about alternative treatments. They should be encouraged to have these treatments first and, should they fail, come back to you. (F) Beware of prolonged and/or expensive unproven treatment methods such as ultrasound therapy17, laser therapy, and shock-wave therapy18. (G) If someone has raised the possibility of a surgical procedure let the patient know the results of a survey of physicians who attended postgraduate courses in orthopedic medicine from 1984 to 1992. Of a total of 338 attendees 72 had a history of lateral epicondylitis, and in all but 2 the process had resolved within 2 years. Few took nonsteroidal antiinflammatory drugs or had a corticosteroid injection. Finally, none of these physicians (they should know better) underwent surgery for their condition19. Epilogue Two weeks have gone by since I wrote the initial paragraph and I am 95% better without any treatment. 2. Hay EM, Paterson SM, Lewis M, Hosie G, Croft P. Pragmatic randomised controlled trial of local corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in primary care. BMJ 1999;319:964-8. [MEDLINE] 3. Smidt N, van der Windt DA, Assendelft WJ, Deville WL, Korthals-de Bos IB, Bouter LM. Corticosteroid injections, physiotherapy, or a wait-and-see policy for lateral epicondylitis: a randomised controlled trial. Lancet 2002;359:657-62. [MEDLINE] 4. Alvarez-Nemegyei J, Canoso JJ. Heel pain: diagnosis and treatment, step by step. Cleve Clin J Med 2006;73:465-71. [MEDLINE] 5. Wolgin M, Cook C, Graham C, Mauldin D. Conservative treatment of plantar heel pain: long-term follow-up. Foot Ankle Int 1994;15:97-102. [MEDLINE] 6. Crawford F, Thomson C. Interventions for treating plantar heel pain. Cochrane Database Syst Rev 2006;3. 7. Smith DL, McAfee JH, Lucas LM, Kumar KL, Romney DM. Treatment of nonspecific olecranon bursitis. A controlled, blinded prospective trial. Arch Intern Med 1989;149:2527-30. [MEDLINE] 8. Weinstein PS, Canoso JJ, Wohlgethan JR. Long-term follow-up of corticosteroid injection for traumatic olecranon bursitis. Ann Rheum Dis 1984;43:44-6. [MEDLINE] 9. Carette S, Moffet H, Tardif J, et al. Intraarticular corticosteroids, supervised physiotherapy, or a combination of the two in the treatment of adhesive capsulitis of the shoulder: a placebo controlled trial. Arthritis Rheum 2003;48:829-38. [MEDLINE] 10. Reeves B. The natural history of the frozen shoulder syndrome. Scand J Rheumatol 1976;4:193-6. 11. Budoff JE, Rodin D, Ochiai D, Nirschl RP. Arthroscopic rotator cuff debridement without decompression for the treatment of tendinosis. Arthroscopy 2005;21:1081-9. [MEDLINE] 12. Brox JI, Staff PH, Ljunggren AE, Brevik JI. Arthroscopic surgery compared with supervised exercises in patients with rotator cuff disease (stage II impingement syndrome). BMJ 1993;307:899-903. [MEDLINE] 13. De Greef I, Molenaers G, Fabry G. Popliteal cysts in children: a retrospective study of 62 cases. Acta Orthop Belg 1998;64:180-3. [MEDLINE] 14. McLauchlan GJ, Handoll HHG. Interventions for treating acute and chronic Achilles tendinitis. Cochrane Database Syst Rev 2006,3. 15. Naredo E, Cabero F, Beneyto P, et al. A randomized comparative study of short term response to blind injection versus sonographic-guided injection of local corticosteroids in patients with painful shoulder. J Rheumatol 2004;31:308-14. [MEDLINE] 16. Lewis M, Hay EM, Paterson SM, Croft P. Local steroid injections for tennis elbow: does the pain get worse before it gets better?: Results from a randomized controlled trial. Clin J Pain 2005;21:330-4. [MEDLINE] 17. D'Vaz AP, Ostor AJ, Speed CA, et al. Pulsed low-intensity ultrasound therapy for chronic lateral epicondylitis: a randomized controlled trial. Rheumatology Oxford 2006;45:566-70. [MEDLINE] 18. Speed CA, Nichols D, Richards C, et al. Extracorporeal shock wave therapy for lateral epicondylitis a double blind randomised controlled trial. J Orthop Res 2002;20:895-8. [MEDLINE] 19. Mens JM, Stoeckart R, Snijders CJ, Verhaar JA, Stam HJ. Tennis elbow, natural course and relationship with physical activities: an inquiry among physicians. J Sports Med Phys Fitness 1999;39:244-8.[MEDLINE]
|